Pharma & CRO Spatial Summit: nPowering the Next Era of Biomarker Discovery

Summit, Webinar

View On Demand

Join NanoString, Illumina, and key customers in the biopharma and Contract Research Organization (CRO) space to hear how the GeoMx® Digital Spatial Profiler (DSP) and CosMx™ Spatial Molecular Imager (SMI) platforms can be used to discover the next generation of biomarkers for cancer and therapeutic response. 

Hear first from Joshua Rusbuldt from Janssen on the use of spatial biology platforms for drug discovery and then from Presage Biosciences CEO Rich Klinghoffer on how the GeoMx DSP and CosMx SMI was used to characterize the effect of an investigational drug on the tumor microenvironment in a Phase 0 clinical trial.

Get an overview of the sequencing capabilities of the NextSeq system with onboard GeoMx run planning with Illumina Product Marketing Manager Sam Hester, and hear Jason Reeves, PhD, Associate Director of Computational Biology at NanoString, discuss considerations for analysis of spatially-resolved gene and protein expression data.

There will be a panel discussion with Q&A at the end of the summit – we welcome your questions during the event!

In partnership with


Elizabeth Schneider, PhD

Senior Global Marketing Manager, NanoString

Espy Anguiano, PhD, MS-MBA

Scientific Market Development Director for Biopharma, NanoString

Joshua Rusbuldt, PhD

Senior Scientist, Immunology Translational Sciences – Gastroenterology, Janssen

Richard Klinghoffer, PhD

Chief Executive Officer, Presage Biosciences

Sam Hester

Staff Product Marketing Manager – Benchtop Systems, Illumina

Jason Reeves, PhD

Associate Director of Computational Biology, NanoString

Nicole Ortogero, PhD

Associate Director of Bioinformatics Software Engineering, NanoString

Circular image of Andrew Brown

Andrew Brown, PhD

Chief Commercial Officer, Sirona Dx